|1.||Weiskirchen, Ralf: 2 articles (05/2012 - 07/2009)|
|2.||Trautwein, Christian: 2 articles (05/2012 - 07/2009)|
|3.||Schmitz, Petra: 2 articles (05/2012 - 07/2009)|
|4.||Wasmuth, Hermann E: 2 articles (05/2012 - 07/2009)|
|5.||Berres, Marie-Luise: 2 articles (05/2012 - 07/2009)|
|6.||Scholten, David: 2 articles (05/2012 - 07/2009)|
|7.||Zaldivar, Mirko Moreno: 2 articles (05/2012 - 07/2009)|
|8.||Zwoliński, J: 1 article (06/2015)|
|9.||Góra-Florek, A: 1 article (06/2015)|
|10.||Dutkiewicz, J: 1 article (06/2015)|
12/01/2001 - "MIG (CXCL9) chemokine gene therapy combines with antibody-cytokine fusion protein to suppress growth and dissemination of murine colon carcinoma."
09/01/2006 - "Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma."
01/01/2009 - "Expression of the chemokine Mig (CXCL9) was increased 2.8-fold in tumors from knockout mice, but no increase was found in serum levels of Mig. "
04/15/2006 - "Histologic analysis of regressing tumors identified infiltration of CD4+ and CD8+ T cells and the expression of CXCL9 chemokine in tumors. "
12/01/2001 - "In addition, the MIG chemokine also induced angiostatic effects in the tumor vasculature. "
03/01/2001 - "The closely related chemokine Mig (monokine induced by interferon-gamma [IFN-gamma]) was also induced in all IL-10-expressing tumors. "
10/01/2010 - "Serial perfusion imaging, and plasma and tumor collections were obtained in mice treated with either placebo or sunitinib alone or in combination with intratumoral injections of the angiostatic chemokine CXCL9. "
02/01/2001 - "The present studies demonstrate a role for the T cell chemoattractant chemokine Mig (monokine induced by IFN-gamma) in contributing to a Th1 response against mouse hepatitis virus infection of the CNS. "
01/01/2015 - "Expression, Inducers and Cellular Sources of the Chemokine MIG (CXCL 9), During Primary Herpes Simplex Virus Type-1 Infection of the Cornea."
06/15/2012 - "Lymphocytes recruited by chemokine CXCL9 are known to be important in control of HSV-2 infection in mice, although the underlying mechanism remains to be addressed. "
01/01/2008 - "Experimental coronavirus retinopathy (ECOR): retinal degeneration susceptible mice have an augmented interferon and chemokine (CXCL9, CXCL10) response early after virus infection."
09/01/2012 - "Human cells mounted vigorous cytokine (tumor necrosis factor alpha [TNF-α] and interleukin-6 [IL-6]) and chemokine (CXCL9, CXCL10, and CXCL11) responses to H5N1 virus infection. "
|5.||Liver Diseases (Liver Disease)
01/01/2007 - "These cytokines generated expression of the chemokine CXCL9 in the liver, thereby enhancing CD8+ T cell infiltration and liver disease in mice. "
09/01/2006 - "These cytokines generated expression of the chemokine CXCL9 in the liver, thereby enhancing CD8+ T cell infiltration and liver disease in mice. "
08/01/2003 - "Using an HBV transgenic mouse model, a reduction of hepatic infiltration and liver disease was achieved recently by administration of antibodies directed against the interferon-gamma-inducible chemokine Mig and against IP-10. "
|3.||Interferon-gamma (Interferon, gamma)
|8.||Monomeric GTP-Binding Proteins
|10.||Glutamic Acid (Glutamate)
|2.||Hematopoietic Stem Cell Transplantation